ChiragParikh United StatesJohns Hopkins University

ChiragParikh
Dr. Chirag R. Parikh, MD, PhD Director, Division of Nephrology, Johns Hopkins University School of Medicine Director, Precision Medicine Center of Excellence for Kidney Disease Dr. Chirag R. Parikh is a Professor of Medicine and the Director of the Division of Nephrology at the Johns Hopkins University School of Medicine. Originally from India, Dr. Parikh attended medical school at Seth G.S. Medical College and KEM Hospital in Mumbai. He completed his fellowship in Nephrology and Hypertension and UNOS Transplant Certification at the University of Colorado, under the mentorship of Dr. Robert Schrier. While completing his fellowship, he also earned a doctorate in Clinical Investigation. Dr. Parikh has been awarded several active NIH grants, has published over 500 original articles, and has been cited over 50,000 times in literature. His research focuses on the translation and validation of novel biomarkers for the diagnosis and prognosis of acute kidney injury. Dr. Parikh is the driving force in a series of discoveries contributing to groundbreaking progress in clinical care for acute kidney injury and setting the stage for creating novel treatment paradigms, based on phenotyping with novel proteins of injury, inflammation, and repair to eliminate the global epidemic of AKI. He followed up these discoveries with paradigm-shifting, multicenter studies of AKI that generated evidence for these proteins for various clinical applications. At Johns Hopkins, Dr. Parikh also directs the Precision Medicine Center of Excellence for Kidney Diseases, leading transformative changes in clinical care and research studies that aim to personalize treatment for each patient. Dr. Parikh's passion for advancing kidney care is evident in his numerous accomplishments. He received the Young Investigator Award from the American Society of Nephrology in 2017, was inducted into the ASCI Society in 2018, and was elected to the AAP in 2021. He is a renowned speaker, presenting at universities and conferences worldwide, and an esteemed mentor who has proven valuable to students, postdoctoral fellows, and faculty.
Upload Picture
https://storage.unitedwebnetwork.com/files/1099/55fb04cafa0d9216d12d2fdb5a55124b.jpg
First Name
Chirag
Last Name
Parikh
Institution
Country.
United States

Saturday, February 8, 2025

Time Session
9:45 a.m.
11:15 a.m.
IK03
GirishNarayen Chair IndiaChief of Nephrology division, udaiomni hospital, Hyderabad,India
Hyeong CheonPark Chair Korea (Republic of)Hyeong Cheon Park, Gangnam Severance Hospital, Yonsei University
Prem PVarma Chair IndiaPrincipal Director
  • What Do We Know About the Association Between AKI and Long-Term Adverse Outcomes?
    IK03-01
    Chi-yuanHsu Speaker United StatesUniversity of California, San Francisco
  • Are Biomarkers in AKI Ready for Prime Time?
    IK03-02
    ChiragParikh Speaker United StatesJohns Hopkins University
  • Community-acquired AKI in the Tropics - Is it a Different Disease?
    IK03-03
    VivekKumar Speaker IndiaPostgraduate Institute of Medical Education and Research, Chandigarh, India
  • Sex as a Biological Variable in the Epidemiology of AKI
    IK03-04
    MarliesOstermann Speaker United KingdomKing's College London
  • Q&A
    IK03-05
Amaltas Hall B101-A